• Flexible Mobility, Adjustable Height How Medical Carts are Redefining Clinical Efficiency

    In modern healthcare settings, adjustable medical carts are becoming vital tools for optimizing workflows and care quality, thanks to their superior mobility and height adjustment capabilities.

    360° Lockable Wheels

    Easy Mobility
    Medical cart trolley systems eliminate fixed workstation limitations. With smooth-rolling casters and stable bases, healthcare staff can effortlessly move equipment wherever needed. This "mobile information" approach reduces unnecessary trips and enhances productivity.

    height adjustable

    Height Adjustment, Care for Caregivers
    The easy height adjustment feature demonstrates user-focused design. Whether at dental workstations during seated procedures or in clinical settings during standing operations, medical professionals can easily position screens at comfortable viewing angles. This ergonomic support helps prevent occupational strain and injuries.

     

    Smart Integration for Enhanced Care
    The combination of mobility and adjustability delivers unprecedented flexibility. Medical cart trolley solutions adapt to various clinical scenarios and user physical needs, improving workflow efficiency while demonstrating institutional commitment to staff wellbeing.

    Medical carts with easy mobility and customizable height settings seamlessly connect information with point-of-care delivery. These medical cart trolley and dental workstation solutions not only optimize clinical processes but also protect caregiver health, offering a powerful yet simple approach to elevating care standards.

  • World Prematurity Day Preeclampsia Tests for Early Preterm Birth Risk Assessment

     

    World Prematurity Day: Preeclampsia Tests for Early Preterm Birth Risk Assessment

     

    1.Introduction: The Silent Threat of Preeclampsi

     

    November 17th is observed as World Prematurity Day, a global effort to raise awareness of the challenges of preterm birth. According to World Health Organization data, approximately 15 million babies are born prematurely worldwide annually, of which nearly 1 million succumb to complications related to preterm birth. Among the key drivers of medically-indicated preterm birth is preeclampsia, a serious multi-system disorder unique to pregnancy.

    Preeclampsia is characterized primarily by new-onset hypertension (≥140/90 mmHg) and proteinuria after 20 weeks of gestation. It can lead to placental insufficiency and fetal growth restriction, thereby triggering preterm birth (delivery before 37 weeks of gestation). The core mechanism of preeclampsia involves an imbalance in placental angiogenesis, with abnormal changes in sFlt-1 and PIGF serving as key early warning signals. 

     

    2.sFlt-1 and PIGF: "Biological Early Warning Indicators" for Preterm Birth Risk

     

    Soluble fms-like tyrosine kinase-1 (sFlt-1): As an anti-angiogenic factor, its over-secretion inhibits the activity of PIGF and VEGF, leading to placental ischemia and hypoxia, which can trigger preterm birth.

     

     

    Placental Growth Factor (PIGF):A pro-angiogenic factor; decreased levels reflect impaired placental function and are positively correlated with preterm birth risk.

    PlGF Test Kit

     

    Interpreting the sFlt-1/PIGF Ratio: A Key Indicator for Risk Stratification

    Ratio ≤ 38: A negative predictive value of 99.3%, can rule out the onset of PE within one week, helping to avoid unnecessary interventions.

    Ratio > 38: Indicates a significantly increased risk of PE within four weeks, warranting intensified monitoring.

    Ratio > 10: The risk of early-onset PE increases fivefold, necessitating vigilance for adverse outcomes such as fetal growth restriction.

     

    3.Clinical Significance :Dynamic Monitoring

     

    Patients with an elevated ratio in the mid-to-late trimester require shorter intervals between prenatal check-ups and intensified blood pressure and fetal monitoring.

    ● First Trimester (11-13+6 weeks): PIGF combined with maternal factors (such as age, BMI) predicts PE risk, guiding early intervention.

    ● Mid-to-Late Trimester (14-34+6 weeks): Dynamic monitoring of the sFlt-1/PIGF ratio enables short-term prediction of early-onset PE and assessment of disease severity.

    ● Patients Diagnosed with PE: Changes in the ratio can predict adverse pregnancy outcomes and guide the timing of delivery.

     

    The realization of this test's value relies on the support of chemiluminescence(CL) resonanceenergy transfer(CRET) technology and chemiluminescence immunoassay analyzers. The Placental Growth Factor ( PIGF) and Soluble fms-like tyrosine kinase-1 (sFlt-1) Test Kit (Homogeneous Chemiluminescent Immunoassay) is a two-site ("sandwich") chemiluminescent immunoassay based on Chemiluminescence (CL) Resonance Energy Transfer (CRET) technology. It can accurately capture minute changes in these biomarkers in the blood through highly specific antigen-antibody reactions, providing reliable data for clinical decision-making. To facilitate clinical interpretation, the sFlt-1/PlGF ratio is automatically computed from a single sample.

    chemiluminescence immunoassay analyzer

     

    Key Advantage (vs. Traditional ELISA):

    ● Exceptional Speed: Reduces the detection time from 3 hours to just 5 minutes.

    ● Operational Simplicity:The homogeneous assay format removes the need for cumbersome washing and separstion steps.

     

    Automated Immunoassay Analyzer

  • World Diabetes Day 2025 - Introducing Poclight’s Enhanced HbA1c Test Solution

     
    1.  Facts & Figures


    World Diabetes Day, held every November 14, reminds us of the growing impact of diabetes worldwide.

    According to the International Diabetes Federation (IDF), more than 500 million adults are living with diabetes, and the number is expected to reach 853 million by 2050.

     

    Diabetes Facts and Figures

     

    However, through prevention, early diagnosis, and regular HbA1c monitoring, we can greatly reduce the impact of diabetes and its complications.

     

    2.  HbA1c as a Diagnostic and Monitoring Tool

     

    HbA1c (Glycated Hemoglobin) is a blood test that reflects your average blood sugar levels over the past 2 to 3 months. It measures the percentage of red blood cells with glucose attached to them, providing a long-term view of blood glucose control, unlike daily tests that only show short-term changes. Because red blood cells live for about 120 days, HbA1c levels give an accurate picture of how well blood sugar has been managed over time.

     

    HbA1c Levels

     

    Diagnostic use: The American Diabetes Association (ADA) and the World Health Organization (WHO) recognize HbA1c as a reliable diagnostic marker for diabetes, with a cutoff value of 6.5% or higher.

     

    Monitoring role: For people with diabetes, regular HbA1c testing helps evaluate how effectively their treatment plan is managing blood sugar levels over the long term.

     

    Recommended HbA1c Testing Frequency

     

    Condition

    Testing Frequency

    Prediabetes

    Once a year

    Annual screening is recommended

    Diabetes: adjusting treatment

    Every 3 months

    Diabetes: stable control

    Every 6 months

    Note: frequency depends on individual status, please follow your doctor’s advice

     

    Common HbA1c Detection Methods

     

    Settings

    Technology

    Typical Use

    Central Lab

    HPLC

    Large hospitals, reference labs

    Point of care

    Immunoassay / Enzymatic

    Small labs, Clinics, near-patient testing, community screening

     

    POCT systems like Poclight’s C5000 dry CLIA platform provide lab-quality results with fast turnaround and easier operation at the point of care.

     

    3.  Poclight’s Upgraded HbA1c Solution

     

    To support better glucose monitoring, Poclight has recently launched a new spectrometer module for the C5000 Analyzer. The module measures hemoglobin levels in a sample using a photometric method and then applies a calculation formula to determine the average percentage of glycated hemoglobin (HbA1c).

     

    Poclight HbA1c Spectrometer

     

    For operation guide, please watch the video below:

     

     

    Poclight Hemoglobin A1c (HbA1c) Test Kit (Homogeneous Chemiluminescence Immunoassay)

    Key Features

    ○ Fast: Results in 5 minutes

    ○ Accurate and Sensitive: High correlation with reference method, NGSP certified; 3.5~20% measuring range, cut-off value 4-6%

    ○ Small Sample: Only 5 μL whole blood required

    ○ Stable: storage at 2–30°C for 18 months

     

    HbA1c Test Kit

     

    ○ Applicable with the C5000 POC CLIA Analyzer: Maintenance-Free

     

    C5000 POCT Analyzer

     

    At Poclight, we remain committed to making precision diagnostics more accessible and reliable for point-of-care settings.

     

    Contact us to learn about local distribution and pricing options for Poclight solutions.

     

  • What advantages does the New Generation Vein Finder have for patients?

    It greatly increases the success rate of venipuncture and reduces the pain of repeated needling


    Pain point: For infants and young children, obese patients, the elderly, those in shock or those who have been receiving intravenous fluids for a long time, their blood vessels are usually thin, deep, brittle or hard to reach. Nurses may need to make multiple attempts to successfully puncture.

    Advantages: Venous visualization devices can directly project real-time images of blood vessels onto the skin surface, like a “vascular map”, allowing medical staff to clearly see the location, direction and bifurcations of blood vessels. This achieves “precise puncture”, avoiding the need for multiple needle pricks caused by repeatedly searching for blood vessels, significantly reducing the patient’s pain and fear.



    2. Significantly improve the experience of patients, especially those in special groups

    Children and infants: Children have thin blood vessels and are very afraid of pain and being touched by strangers. Repeated injections can cause great psychological pressure to both children and parents. The vein finder can quickly locate blood vessels, shorten operation time and soothe the emotions of parents and children.

    Elderly patients: The blood vessels of the elderly have poor elasticity and are prone to rolling, and their skin is loose. Visualization technology can help nurses find the most ideal and solid puncture point, avoiding vascular rupture or bruising.

    Obese patients: Thick subcutaneous fat completely conceals the visual and tactile cues of blood vessels. The vein finder can “penetrate” the surface fat and reveal the deep blood vessels, solving the biggest problem.

    Patients with cancer or chronic diseases: Long-term chemotherapy or intravenous infusion can damage blood vessels, leading to their hardening and fragility. Using a vein finder can select relatively healthy vascular segments for puncture, protecting the patient’s precious vascular resources.



    3. Enhance safety and reduce the risk of complications

    Reduce vascular damage: Precise puncture reduces accidental injury to the vascular wall, thereby lowering the probability of post-puncture bruising, hematoma, and phlebitis.

    Avoid accidental arterial puncture: In some cases, arteries and veins are very close to each other. Clear vascular images can help medical staff distinguish between arteries and veins and prevent accidental puncture of arteries. It is especially an important safety aid for inexperienced operators.

    Protecting blood vessels: For patients who need long-term intravenous infusion, the puncture sites can be rotated in a planned manner to avoid excessive damage to the same blood vessel.



    4. Shorten the preparation time and improve the efficiency of medical treatment

    In busy emergency rooms, outpatient clinics or physical examination centers, it is crucial to quickly establish intravenous access. The use of a vein finder can quickly locate blood vessels, significantly reducing the preparation and search time before puncture, accelerating the overall diagnosis and treatment process, and reducing the time patients spend waiting and being exposed to a tense environment.



    5. Alleviate psychological anxiety and fear

    For many people, "getting an injection" itself is a source of fear. When patients see medical staff looking troubled because they can't find the blood vessels, it intensifies their sense of tension. When the device clearly displays the blood vessels and the medical staff confidently succeed in one attempt, this "visualization" technology will bring great psychological comfort and trust to the patients, thus increasing their cooperation.



    Also welcome to contact us, we are ZD Medical Inc.
    Tel : +86-187 9586 9515
    Email : sales@zd-med.com
    Whatsapp/Mobile : +86-187 9586 9515

  • What are the four key points that Vein Finder must pay attention to?

    Key Point One: Imaging technology and clarity


    This is the core indicator, which directly determines the practical effect of the equipment.

    Core technologies: Currently, there are mainly two mainstream technologies, namely infrared imaging and ultrasonic imaging. Infrared light equipment is non-contact and forms images based on the differences in the absorption of near-infrared light by hemoglobin in blood vessels. Ultrasound, on the other hand, directly observes the structure of blood vessels and blood flow through sound waves.

    Image quality: Focus on the resolution, contrast and depth of the imaging. High-quality imaging devices can present clear vascular images that contrast sharply with the surrounding tissues on patients of different skin colors and body weights. Especially for deep and tiny blood vessels, whether they can be clearly displayed is the key.

    Real-time performance: The image should have no delay and be able to follow the movement of the probe in real time, which is crucial for the dynamic puncture process.



    Key Point Two: Patient adaptability and safety

    The equipment must be capable of serving a wide range of patient groups and be absolutely safe.

    Skin color adaptability: Excellent equipment should have the ability to overcome “skin color bias”, effectively imaging both fair and dark skin. Find out if the device has special calibrations or modes for different skin tones.

    Body type adaptability: For patients with obesity, edema or emaciation, whether the penetration ability and imaging effect of the equipment are stable.

    Safety level: Confirm that the light source energy of the equipment is within the absolutely safe range of non-ionizing radiation and has obtained the relevant medical device registration certification.



    Point Three: Ease of use and workflow integration

    The equipment needs to be integrated into the existing clinical process rather than adding to the burden.

    Ease of operation: Can the device be used immediately upon startup? Is the calibration process complicated? Is the interface intuitive? Ideally, nurses or doctors should be able to get started after a brief training.

    Portability and Design: Is the device Handheld Vein Finder or desktop Vein Finder ? How is the battery life? Whether it is lightweight and ergonomically designed, making it convenient to move and use between wards, emergency rooms and operating rooms.

    Sterility and disinfection: Are the parts that come into contact with patients easy to clean and disinfect? Are disposable sterile protective covers provided? This is directly related to infection control.



    Key Point Four: Functionality and Augmented Reality Experience

    Advanced functions can significantly enhance clinical value.

    AR augmented reality projection: Many modern venous imaging devices can directly project vascular images onto the patient’s skin, achieving “what you see is what you get”, allowing the operator not to switch their line of sight back and forth between the screen and the skin, greatly improving the success rate of puncture and the user experience.

    Vascular recognition mode: Is there a special mode, such as only showing arteries or veins (by identifying the direction of blood flow), which is very important for certain special treatments?

    Image and data Management: Does the device support image taking, archiving, or connection to the hospital information system? This is of certain value for case recording, teaching and remote consultation.


    Also welcome to contact us, we are ZD Medical Inc.
    Tel : +86-187 9586 9515
    Email : sales@zd-med.com
    Whatsapp/Mobile : +86-187 9586 9515

  • Poclight IgE Assay Accurate Insights into Allergic Diseases

     

    1.  What is IgE?

     

    In our blood, there exists a special class of protein known as immunoglobulin, which is an important component of the immune system. Among them, IgE (immunoglobulin E), despite its extremely low concentration, accounting for only 0.002% of the total immunoglobulin, it acts as a key "messenger" in triggering allergic reactions. This antibody produced by B lymphocytes primarily protects the human body in two ways: one is to resist parasitic infections, and the other is to trigger an immune response when encountering allergens.

     

    When allergens (such as pollen, dust mites or certain foods) enter the human body, the immune system recognizes them as "foreign invaders" and prompts B cells to produce IgE antibodies against the allergen. These IgE will specifically bind to the surface of mast cells and basophils, causing the body to enter a "sensitized state". When exposed to the same allergen again, IgE immediately activates the "alarm system", prompting cells to release inflammatory mediators such as histamine, triggering allergic symptoms like sneezing, itchy skin, and breathing difficulties - this is the fundamental principle of what we commonly refer to as an allergic reaction.

     

    2.  IgE Testing: Purpose and Applications

     

    IgE detection has become a critical tool in the diagnosis of allergic diseases.

     

    IgE Assay Application

     

    Clinical significance: Studies show that approximately 30% of patients with allergic diseases exhibit significantly elevated levels of total serum IgE. Moreover, specific IgE testing demonstrates over 85% accuracy in identifying the types of allergens involved. This test is mainly applicable to three types of people:

    ✓ Patients with recurrent skin itching, urticaria, allergic rhinitis and other symptoms.

    ✓ Individuals with a history of asthma and unknown cause.

    ✓ High-risk groups with a family history of allergic diseases.

     

    Note: IgE test results must be interpreted in conjunction with clinical symptoms. For instance, in patients with hay fever, allergen-specific IgE levels may rise 2-4 weeks before the pollen season begins. In cases of food allergy, relevant IgE antibodies can trigger an immune response within 1-2 hours after ingestion of the allergenic food. Through dynamic monitoring of IgE levels, physicians can not only confirm a diagnosis but also develop personalized desensitization treatment plans, which have been shown to reduce the risk of acute asthma attacks by 40%-60%.

     

    3.  From Testing to Management: Comprehensive Prevention and Control of Allergic Diseases

     

    IgE testing is only the first step in the management of allergic diseases. Clinical practice has shown that personalized prevention and control plans, developed based on test results, can improve patients' quality of life scores by 35%~50%. For patients allergic to dust mites, in addition to the use of antihistamines, regular environmental control measures, such as using mite-proof bedding and air purifiers, can reduce the frequency of symptom episodes by 40%. Patients with food allergies, on the other hand, need to strictly avoid allergenic foods and carry an epinephrine auto-injector at all times in case of accidental exposure.

     

    IgE Test Kit

     

    With advances in precision medicine, IgE testing technology is also continuously evolving. The new generation of testing methods can not only quantitatively analyze antibody levels but also predict the severity of allergic reactions by detecting IgE subtypes.

     

    In an era of ongoing iteration in in vitro diagnostic technologies, Poclight IgE test kit, with its innovative technology, exceptional performance, user-friendly operation, and reliable quality, offers a new option for the precise diagnosis of allergic diseases. In the future, by integrating genetic testing and artificial intelligence algorithms, we hope to achieve early warning and precise intervention for allergic diseases, helping more people break free from the burden of allergies.

     

    Advantages of Poclight IgE Test Kit: Innovative CRET Technology Enables Precision "Signal-Switch" Detection

     

    C5000 POCT Analyzer

     

    Technology Principle:

    ✓ Utilizes a homogeneous chemiluminescence approach.

    ✓ Integrates antigen-antibody reactions with chemiluminescent signals.

     

    Workflow:

    ● The target substance binds with an acridinium ester-labeled DNA antibody to form an immunocomplex.

    ● Graphene oxide quenches the remaining unbound acridinium ester-labeled DNA fragments.

    ● This homogeneous process eliminates the need for separation and washing steps.

    ● A chemiluminescent reaction is initiated by adding an excitation solution.

     

    Performance Specifications:

    ✓ High Sensitivity: Detection sensitivity of 0.1 IU/mL.

    ✓ Wide Linear Range: 0.1–2500 IU/mL, fully meeting clinical testing requirements.

    ✓ Excellent Precision: Intra-assay CV ≤10% and inter-assay CV ≤15%, ensuring stable and reliable results.

    ✓ Rapid detection: in just 5 minutes, minimal sample volume of 50 µL, simple operation, low cost, high-quality CLIA methodology, innovative CRET patented technology, precise results, and a wide linear detection range.

    ✓ Ease of Use: Minimal training required

     

    Key Advantage (vs. Traditional ELISA):

     

    ●  Exceptional Speed: Reduces the detection time from 3 hours to just 5 minutes.

    ●  Operational Simplicity: The homogeneous assay format removes the need for cumbersome washing and separation steps.

    Compatible with Poclight C5000 POC CLIA Analyzer

     

     

    Operation

     

    To learn more about cooperation regarding Poclight's 5-generation CLIA solutions, please contact us.

     

  • World Stroke Day Poclight CRET for Hidden Stroke Detection

     
    1.  The Invisible Warning: Activated Platelets

     

    October 29 marks World Stroke Day, a reminder to pay attention to brain health and take action to prevent strokes, one of the leading causes of death and disability worldwide.

    Strokes can occur suddenly, and certain physiological changes may precede clinical symptoms. Early detection is therefore essential for timely risk assessment and intervention.

     

    Many people associate stroke with high blood pressure, high cholesterol, and atherosclerosis. While these are important risk factors, there’s a crucial, often overlooked element — abnormal platelet activation.

    Normal platelets help stop bleeding, but when excessively activated, they become overly sticky and prone to clumping. Like tiny “time bombs,” they can form blood clots that block cerebral blood vessels, leading to ischemic stroke.

    Traditional blood tests may not fully reflect platelet activation; direct monitoring of platelet functional state provides more comprehensive information.

     

    2.  The Gold Standard: Platelet Activation Markers

     

    Early detection of platelet activation is key to predicting thrombotic events. Important markers include:

     

    Platelet Activation Markers

     

    ● CD62P (P-Selectin): Recognized as the gold standard for platelet activation. Its surface expression signals the initiation of clot formation.

    ● PAC-1: A widely accepted marker for early platelet activation.

    ● CD42a, CD42b, CD41, CD61: Maintain platelet structure and function, mediating aggregation, adhesion, and secretion.

    These markers allow clinicians to precisely assess platelet activation and intervene before stroke occurs.

     

    Testing Significance

     

    1)  Personalized Antiplatelet Therapy

    Provides precise guidance for the use of antiplatelet drugs such as aspirin and clopidogrel, enabling individualized treatment.

    2)  Stroke Risk Assessment

    Detects hidden hypercoagulable states in time, offering early warning for cardiovascular and cerebrovascular events.

    3)  Medication Guidance & Efficacy Monitoring

    Evaluates whether antiplatelet therapy is effective and identifies potential “drug resistance,” allowing timely adjustment of treatment plans.

     

    3.  CRET Platelet Activation Measurement

     

    Poclight Platelet Activation Function Analyzer: Real-Time, Dynamic, and Precise

    Poclight CRET Analyzer and reagents offers a powerful tool for platelet monitoring, helping clinicians make informed decisions regarding transfusion strategies, bleeding/thrombosis risk prediction, and treatment optimization.

     

    Poclight Platelet Activation Features

     

    With CRET Measurement, clinicians can detect the “invisible” culprits of stroke early, enabling timely intervention and improved patient outcomes.

     

    For detailed information and partnership options, please contact us.

     

  • What benefits does Optical Coherence Tomography bring to the healthcare industry?

    I. (Core Value: Unparalleled Diagnostic Capability


    High-resolution, non-invasive “optical biopsy”

    Traditionally, to make a clear diagnosis of many diseases, a biopsy was required, which involves taking a small piece of tissue and observing it under a microscope. This is an invasive operation.

    OCT provides cross-sectional images similar to biopsies, but it is completely contactless and non-invasive. Doctors can directly observe the microstructure of the surface and subsurface layers of tissues inside the body without the need for cutting, significantly reducing risks and patient discomfort.



    2. Real-time imaging, guiding treatment

    OCT imaging is extremely fast and can provide images in real time. This enables doctors to immediately assess the condition of the tissue during surgery or interventional treatment, thereby making more accurate decisions.

    For instance, during cardiovascular interventional surgery, doctors can view in real time the nature of the plaques within the blood vessels and the adhesion of stents.



    Ii. (Main Application Fields and Specific Assistance)

    The application of OCT has expanded from ophthalmology to multiple medical fields. Here are some of its most important applications:

    Ophthalmology - the most mature and widely applied field

    This is a prime example of the success story of OCT technology, which has completely transformed the diagnosis and treatment of retinal diseases.

    Help

    Diagnosis of macular diseases: Precise diagnosis and staging of age-related macular degeneration (AMD), macular edema, macular holes and other diseases is the gold standard.

    Glaucoma management: By precisely measuring the thickness of the retinal nerve fiber layer (RNFL), early diagnosis of glaucoma and objective monitoring of disease progression can be achieved.

    Diabetic retinopathy: Early detection of subtle changes and edema in the retina to guide treatment.

    Impact on the industry: It has led ophthalmic diagnosis from subjective two-dimensional fundus photography to an era of objective and quantitative three-dimensional microstructure analysis.



    2. Cardiology - A rapidly developing frontier field

    Intravascular OCT (IV-OCT) enters the interior of blood vessels through slender catheters for imaging.

    Help

    Precise assessment of plaques: Clearly distinguish lipid plaques, fibrous plaques and calcified plaques, and identify easily ruptured “vulnerable plaques”, which is something that traditional angiography cannot achieve.

    Optimizing stent implantation: During percutaneous coronary intervention (PCI), guiding doctors to select stents of appropriate size and accurately assessing whether the stents are fully adhered and sufficiently dilated after the operation significantly reduces the risk of restenosis and thrombosis after the operation.

    Impact on the industry: It has advanced coronary intervention therapy from the era of “walking according to the route map” with angiography to the era of “navigating with a high-brightness map on” with precision.



    3. Combination of oncology and endoscopy

    Integrating the OCT probe into the endoscope enables deep scanning of suspicious areas simultaneously during endoscopic examinations of the digestive tract, respiratory tract, etc.

    Help

    Early cancer diagnosis: In the gastrointestinal tract, respiratory tract, bladder and other areas, distinguish benign lesions from early cancer, guide the biopsy location, and increase the positive rate of biopsy.

    Determine the tumor boundary: Assist surgeons in determining the precise boundary of the tumor during surgery to ensure complete resection while preserving as much healthy tissue as possible.

    Impact on the industry: It has enhanced the depth and accuracy of endoscopic examinations and promoted the screening and diagnosis capabilities for early-stage tumors.



    4. Dermatology

    Skin OCT is similar to ophthalmic OCT and can perform high-resolution imaging of the skin’s surface layer.

    Help

    Non-invasive diagnosis: It assists in the diagnosis of skin tumors such as basal cell carcinoma and melanoma, as well as inflammatory diseases like eczema and psoriasis.

    Treatment monitoring: Non-invasive monitoring of the efficacy of drug treatment or laser treatment.

    Impact on the industry: It has reduced the need for some diagnostic biopsies and provided new tools for the dynamic monitoring of skin diseases.



    Iii. (Summary of the Overall Impact on the Healthcare Industry)

    1. Enhance the level of diagnosis and treatment: Early diagnosis, precise staging and personalized treatment of diseases have been achieved.

    2. Enhance patient experience: Through non-invasive or minimally invasive examinations, patients’ pain, risk of complications and recovery time are reduced.

    3. Reduce medical costs: Although OCT devices themselves are expensive, they can lower overall medical expenses in the long run by avoiding unnecessary surgeries, optimizing the treatment process and reducing complications.

    4. Promoting scientific research development: It provides powerful in vivo imaging tools for medical research, accelerating the development of new drugs and in-depth understanding of disease pathological mechanisms.


  • Expand Your Diagnostic Portfolio - Rapid Tumor Marker Testing with Poclight CLIA Solutions

    1.  Global Cancer Burden: Facts & Figures

    The Rising Global Cancer Burden

    According to the latest report from the World Health Organization (WHO) and its cancer agency, IARC, there were approximately 20 million new cancer cases and 9.7 million deaths worldwide in 2022, with around 53.5 million people alive within five years of a cancer diagnosis.

     

    Global Cancer Incidence

     

    Lung, breast, and colorectal cancers were the three most common types, with lung cancer remaining the leading cause of death. Low-income countries face higher mortality due to late diagnosis and inadequate care.

     

    By 2050, global new cancer cases are projected to reach 35 million, with the largest increases in low- and middle-HDI countries. WHO calls for strengthened cancer care coverage and investment to ensure accessible, high-quality cancer diagnosis and treatment for all.

     

    The Importance of Early Screening

    ● Up to 40% of cancer-related deaths could be prevented through early detection and timely intervention. (The Lancet Global Health)

    ● Developed countries show higher screening coverage, while accessibility remains a challenge in developing regions.

    ● The trend toward multi-cancer early detection (MCED) is accelerating globally, promoting a more comprehensive approach.

     

    For Breast Cancer Awareness Month (October)

    ● Breast cancer is the most common cancer among women worldwide.

    ● Self-examination is recommended starting at age 20.

    ● Women over 40 are advised to undergo imaging combined with biomarker screening every 1–2 years.

    ● Early detection (Stage I) can lead to a 5-year survival rate exceeding 90%.

    Recommendations and statistics are based on sources, including WHO guidelines, the American Cancer Society (ACS), EUSOMA guidelines, and global cancer data from GLOBOCAN/IARC and the NCI SEER database.

     

    2.  Key Tumor Markers and Their Clinical Significance

     

    Biomarker

    Associated Cancer Type(s)

    Clinical Use

    PSA

    Total Prostate-specific antigen (tPSA)Test Kit

    Prostate Cancer

    Routine screening marker; early detection and therapy monitoring

    CEA

    Multiple Cancers (colorectal, lung, breast, etc.)

    Broad-spectrum marker for diagnosis aid and recurrence monitoring

    AFP

    Liver Cancer

    Key indicator for hepatocellular carcinoma screening and differentiation

    CYFRA21-1

    Lung Cancer (especially squamous type)

    Supports diagnosis and treatment evaluation

    CA19-9

    Pancreatic & Gastrointestinal Cancers

    Digestive system malignancies and therapy monitoring

    CA125

    Ovarian Cancer

    Screening and disease progression evaluation in female patients

     

    Combining markers increases sensitivity and specificity by compensating for individual testing limitations:

    ● Ovarian cancer: CA125 + HE4 achieves 93.8% accuracy.

    ● Pancreatic cancer: CA19-9 + CEA + CA125 raises sensitivity to 82%.

    ● Prostate cancer: f/t PSA ratio reduces false positives by 30% in the gray zone.

     

    Application Department

     

    3.  Poclight’s Innovative Diagnostic Solutions

     

    In today’s evolving healthcare landscape, laboratories and diagnostic providers are seeking faster, more reliable, and accessible cancer testing solutions, yet traditional immunoassay systems often require high costs, long turnaround times, and complex operation.

    Poclight offers a comprehensive portfolio that empowers both distributors and laboratories to expand access to high-quality cancer diagnostics anywhere, anytime.

     

    1) Advanced Platform: C5000 Dry Chemiluminescence Immunoassay Analyzer (Dry CLIA Analyzer)

    C5000 CLIA Analyzer

     

    2) Featured Tumor Marker Panel

    ✓ Combined tumor marker testing: PSA, CEA, AFP, CYFRA21-1, CA19-9, CA125

    ✓ Covers multiple major cancer types (liver, lung, prostate, gastrointestinal, ovarian)

    ✓ Fast, accurate, and suitable for hospitals, health centers, and primary care facilities

     

    Poclight Tumor Markers Specifications

     

    ✓ Rapid detection in just 5 minutes, minimal sample volume of 50 µL, simple operation, low cost, high-quality CLIA methodology, innovative CRET patented technology, precise results, and a wide linear detection range.

     

    Ease of Use: Minimal training required

    Operation

     

    More tumor marker and other assays in progress

     

    Poclight Biotech is actively seeking global partners who share our vision for accessible, high-quality diagnostics.

    Reach out to us to explore collaboration opportunities or to learn how our solution can fit into your portfolio.

  • How Optical Coherence Tomography Constructs a “Data Vault” Compliant with Cybersecurity Protection Standards

    The first step: Demarcate the boundaries of the “safe” and the environment (regional boundary security)
    OCT devices

    should not be directly exposed to public networks. First, it is necessary to plan the security domain.

    1. Network partition isolation

      Medical equipment dedicated network: OCT devices, PACS servers, image storage servers, etc. are classified into an independent VLAN and logically isolated from the office network and the Internet.

      Firewall policy: Deploy firewalls at the network boundary and strictly follow the “principle of least privilege”. Only specific and necessary ports and IP addresses are allowed for communication (for example, port 104 of the DICOM protocol, a specific port of the hospital information system). Any illegal external access is prohibited.
    2. Physical Access Control

      The computer room where OCT equipment and core servers are placed should implement strict physical access control and video surveillance management to prevent unauthorized physical contact.

      Step 2: Build a sturdy box for the "safe" (secure computing environment)
      This is the core layer that protects the data itself.
      OCT Equipment and Terminal Security:
      Strengthen the operating system: Enhance the security of the operating system of the industrial control computer or computer built into the OCT device, as well as that of the diagnostic workstation.
      Anti-virus software: Install hospital-specific anti-virus software and update the virus database regularly.
      Identity authentication: It is mandatory to log in to the system with a unique personal username and a strong password. For the third-level information security protection, two-factor authentication should be mandatory.
    3. Data storage encryption (lock of the safe) :

      Static data encryption: All OCT image data must be encrypted when stored on the disk. Available options:

      Transparent database encryption: Encrypting sensitive fields in the database.

      Storage layer encryption: Encrypt the entire disk or volume using the built-in encryption function of the storage device or operating system-level encryption.

      File-level encryption: Encrypting a single DICOM file.

      Key management: Encryption keys must be uniformly managed by a professional key management system, stored separately from encrypted data, and rotated regularly. This is the key point of the requirements for the equal protection.
    4. Application Security

      Ensure that the PACS software and OCT device software themselves have no known high-risk vulnerabilities, and conduct regular security assessments.

      Step 3: Ensure "safety during transportation" (communication network security)
      When data is transmitted between OCT devices, PACS servers and diagnostic workstations, it is necessary to prevent eavesdropping and tampering.
    5. Transmission encryption

      Enforce the use of encryption protocols such as DICOM over TLS or DICOM over HTTPS to replace the traditional plaintext DICOM protocol. This ensures that data is encrypted when transmitted over the network, similar to HTTPS protecting web page communication.

      For scenarios such as remote consultation that require cross-internet transmission, a VPN encrypted tunnel must be established.

      Step 4: Establish a monitoring and management center for the "safe deposit box" (Safety Management center)
      This is the brain and nerve center of the "safe", responsible for monitoring, auditing and emergency response.
    6. Log audit (recording who opened the box) :

      Collect all logs related to OCT data centrally, including: user login/logout logs, logs of OCT image creation, modification, deletion, access, printing, export and other operations. These logs must be retained for no less than six months.

      The information security protection level requires that the content of logs cannot be tampered with, so it is necessary to deploy a professional log auditing system.
    7. Database Audit

      For operations that directly access the database, a database auditing system is deployed to record all access behaviors to OCT data tables, especially high-risk operations.
    8. Operation and Maintenance Management and Security Audit

      Video the operations of system administrators and record instructions to achieve traceability.

      Regularly conduct security risk assessments and vulnerability scans.
    9. Data Backup and Recovery (Spare key for the safe) :

      Formulate a complete data backup strategy and regularly back up OCT image data and related patient information.

      Regularly conduct disaster recovery drills to ensure that business and data can be quickly restored in the event of data loss, system downtime or ransomware attacks. Backup data also needs to be encrypted for protection.



      Also welcome to contact us, we are ZD Medical Inc.
      Tel : +86-187 9586 9515
      Email : sales@zd-med.com
      Whatsapp/Mobile : +86-187 9586 9515